Akermin today announces the signing of a Cooperative Agreement for a commercial-scale demonstration project that will incorporate its biocatalyst technology. This DKK 42 million ($7 million US), three-year demonstration project is partially-funded through a grant from the Danish Energy Agency (EUDP).
Illumina CSPro™ certification has been completed for sequencing on HiSeq and MiSeq, gaining entry to an elite group of Illumina genomics service providers globally.
Akermin, Inc., a St. Louis company developing novel biocatalytic solutions for efficient removal of carbon dioxide (CO2) from industrial gas streams, announced that its field pilot plant has achieved a significant milestone by completing over 1,600 hours of operation, capturing CO2 from the flue gas exhaust of a coal-fired power plant.
Akermin announces the successful commissioning and testing of its proprietary Biocatalyst Delivery System at the National Carbon Capture Center in Wilsonville, AL.